• Home
  • Stock
  • Natco Pharma Fundamental Analysis
  • Natco Pharma Fundamental Analysis

Natco Pharma fundamental analysis

NATCOPHARM

HealthcareLarge

869.3

39.15 (4.72%)
Last updated on 20 Nov, 2025 | 15:59 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Natco Pharma Fundamentals

P/E Ratio

9.66

P/B Ratio

1.72

Div. Yield

0.72

Sector P/E

37.59

Sector P/B

3.65

Sec. Div. Yield

0.57

  • Natco Pharma Fundamentals is currently trading with a P/E Ratio of 9.66, compared to the sector average of 37.59. Its P/B Ratio stands at 1.72, while the sector’s is 3.65. In terms of returns, the stock offers a Dividend Yield of 0.72%, which is than the sector’s 0.57%.

Natco Pharma Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Natco Pharma reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.